USFDA inspection at Emcure Pharmaceuticals API facility

The United States Food and Drug Administration (USFDA) had conducted a current Good Manufacturing Practices (cGMP) inspection of Company's API manufacturing facility located at M.I.D.C., Kurkumbh, Taluka - Daund, Pune - 413802, Maharashtra, from February 19, 2025 to February 25, 2025. On conclusion of the inspection, the company received two observations in Form 483.

Relonchem receives marketing authorization for Ibuprofen and Paracetamol tablets

Marksans Pharma Limited has announced that its wholly owned subsidiary in UK Relonchem Limited has received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).